Goldman Sachs’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-104,244
Closed -$636K 6916
2021
Q3
$636K Sell
104,244
-1,009,901
-91% -$6.29M ﹤0.01% 5053
2021
Q2
$9.17M Buy
1,114,145
+95,794
+9% +$815K ﹤0.01% 2769
2021
Q1
$9.12M Buy
1,018,351
+190,824
+23% +$2.19M ﹤0.01% 2651
2020
Q4
$9.55M Sell
827,527
-82,769
-9% -$962K ﹤0.01% 2510
2020
Q3
$9.48M Buy
910,296
+184,270
+25% +$2.26M ﹤0.01% 2375
2020
Q2
$9.55M Buy
726,026
+621,879
+597% +$6.45M ﹤0.01% 2307
2020
Q1
$820K Sell
104,147
-58,545
-36% -$882K ﹤0.01% 3889
2019
Q4
$3.37M Buy
162,692
+33,045
+25% +$557K ﹤0.01% 3257
2019
Q3
$1.78M Sell
129,647
-21,759
-14% -$258K ﹤0.01% 3625
2019
Q2
$1.86M Buy
151,406
+26,549
+21% +$306K ﹤0.01% 3602
2019
Q1
$1.56M Sell
124,857
-279,191
-69% -$3.73M ﹤0.01% 3791
2018
Q4
$4.57M Buy
404,048
+244,709
+154% +$3.84M ﹤0.01% 2964
2018
Q3
$2.98M Buy
159,339
+40,802
+34% +$937K ﹤0.01% 3325
2018
Q2
$3.06M Buy
118,537
+15,961
+16% +$414K ﹤0.01% 3309
2018
Q1
$2.3M Buy
102,576
+36,661
+56% +$895K ﹤0.01% 3496
2017
Q4
$1.65M Buy
65,915
+9,159
+16% +$224K ﹤0.01% 3934
2017
Q3
$1.37M Buy
56,756
+4,953
+10% +$116K ﹤0.01% 4312
2017
Q2
$1.05M Sell
51,803
-13,333
-20% -$278K ﹤0.01% 4411
2017
Q1
$1.75M Buy
65,136
+31,817
+95% +$650K ﹤0.01% 3880
2016
Q4
$634K Buy
33,319
+341
+1% +$6.52K ﹤0.01% 4850
2016
Q3
$644K Buy
32,978
+12,119
+58% +$205K ﹤0.01% 4799
2016
Q2
$312K Sell
20,859
-13,524
-39% -$170K ﹤0.01% 5296
2016
Q1
$316K Buy
34,383
+7,272
+27% +$88.2K ﹤0.01% 5227
2015
Q4
$522K Buy
27,111
+7,671
+39% +$133K ﹤0.01% 4889
2015
Q3
$289K Sell
19,440
-51
-0.3% -$1.2K ﹤0.01% 5645
2015
Q2
$427K Sell
19,491
-1,019
-5% -$20.6K ﹤0.01% 5349
2015
Q1
$462K Buy
+20,510
New +$475K ﹤0.01% 5215